PJGZX
Price
$21.20
Change
-$0.62 (-2.84%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

PJGZX vs RMFCX

Header iconPJGZX vs RMFCX Comparison
Open Charts PJGZX vs RMFCXBanner chart's image
PGIM Jennison Focused Value Z
Price$21.20
Change-$0.62 (-2.84%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
PJGZX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PJGZX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PJGZX is a StrongBuy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. PJGZX (237M). RMFCX pays higher dividends than PJGZX: RMFCX (1.69) vs PJGZX (1.05). PJGZX was incepted earlier than RMFCX: PJGZX (28 years) vs RMFCX (23 years). PJGZX is a more actively managed with annual turnover of: 37.00 vs. RMFCX (25.00). PJGZX has a lower initial minimum investment than RMFCX: PJGZX (0) vs RMFCX (250). PJGZX annual gain was more profitable for investors over the last year : 19.41 vs. RMFCX (9.39). PJGZX (37.65) and RMFCX (36.51) have equivalent 5 years return.
PJGZXRMFCXPJGZX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years23 years-
Gain YTD18.5768.896209%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets237M98.7B0%
Annual Yield % from dividends1.051.6962%
Returns for 1 year19.419.39207%
Returns for 3 years14.4611.57125%
Returns for 5 years37.6536.51103%
Returns for 10 years12.8258.1722%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.850.02
+2.57%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc